Hitiq (ASX:HIQ) said it expects up to AU$6.3 million in potential revenue from its agreement with US-based Shock Doctor, according to a June 13 filing with the Australian bourse.
On June 11, the company signed an agreement to design a mouthguard that integrates the company's Proteqt technology, with plans to produce 20,000 units this year and 100,000 units in 2026.
The non-conditional agreement is for five years with the option to be renewed for an additional five years. The product will be distributed in Australia and the UK, the filing said.